Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Standardized protocol guides therapies to reduce VTE after arthroplasty

Key clinical point: A risk assessment protocol to guide choice of venous thromboembolism prophylaxis reduced risk of events without altering bleeding risk.

Major finding: The rate of pulmonary embolism (0.34% vs. 0.62%; P = .004) was significantly lower for those managed with the protocol.

Data source: A single-center prospective study.

Disclosures: Dr. Wylie reported a financial relationship with Arthrex.

Citation:

Wylie J. AAOS 2020.